Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatic Disease Does Not Preclude Pregnancy

Ruth Jessen Hickman, MD  |  Issue: November 2017  |  November 9, 2017

Some physicians may not address the topic, thinking that patients will ask if they have questions.9 Some evidence suggests that patients often desire such counseling, but often rely on their doctors to bring up the subject.12 Some patients may be interested but simply forget to ask, or they may not realize how relevant the topic is to their rheumatologic disease.9

Dr. Birru Talabi recommends patient-centered, nonjudgmental, open-ended questions when discussing family planning. She suggests that the following phrasing may work well: “Tell me a bit about your life and where pregnancy fits in your plans. I ask because I’d like to work with you to try to make sure things turn out the way you’d like them to.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She notes that many women aren’t clear about their reproductive goals. She advocates empowering women to come up with a pregnancy plan if they do want to become pregnant or formulate a contraceptive plan if they do not.

She also warns not to make assumptions about who needs family planning conversations. “I think we should have these conversations with everybody, all women of reproductive age, no matter what their sexual orientation is, no matter their age, whether or not they are married and whether or not they are on Medicaid, don’t have insurance or don’t have a job.” She notes that even women with severe disease may be having sex and at risk of unintended pregnancy. These women may be the least likely to get contraceptive counseling, though they are the ones who may most be in need of it.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Birth Control Methods

Dr. Sammaritano emphasizes that patients and physicians must realize that not all contraceptive options are equally effective. She notes, “The choice of contraception should be based on what is most effective and what is safe and acceptable for each individual patient.” She adds, “Long-acting reversible contraceptives—IUDs and subdermal implants—are the most effective, and they should be encouraged when possible.” When picking a method, clinicians and patients should also consider reversibility of the method, any noncontraceptive benefits, side effects, costs and convenience of the method.2

There are relatively few true birth control contraindications for women with rheumatic disease. Because of the increased risk of thrombosis, certain populations should avoid combined contraceptives containing estrogen. These include women with uncontrolled lupus or women with increased risk of thrombosis due to positive antiphospholipid antibody (aPL), due to history of vasculitis, nephritis or thrombosis, or from other factors.6

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:Conditions Tagged with:Autoimmune diseasecontraceptivecounselingEducationInflammatory MyopathiesLupusoutcomepatient carepregnancyRheumatic DiseaseRheumatoid arthritisrheumatologistriskSystemic sclerosisVasculitisWomen

Related Articles

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    Improved Family Planning Counseling Needed

    May 18, 2018

    In the U.S. today, approximately 45% of pregnancies are unintended or unplanned.1 Although this rate is considerably lower than in the past, women with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) or inflammatory myopathies tend to have better pregnancy outcomes if their disease is well controlled when they conceive. In addition, women taking certain medications…

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

    Baby on Board: The Rheumatologist’s Role in Family Planning for Patients with Lupus

    January 2, 2020

    For patients with lupus, family planning discussions are vital to achieving positive pregnancy outcomes & maintaining overall health…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences